Reagents for Astatination of Biomolecules: Comparison of the in Vivo Distribution and Stability of Some Radioiodinated/Astatinated Benzamidyl and nido-Carboranyl Compounds

Bioconjugate Chemistry

Volumn 15, Issue 1, 2004, Pages 203-223

  Wilbur, D Scott ^a   Chyan, Ming Kuan ^a   Hamlin, Donald K ^a   Kegley, Brian B ^a   Risler, Reudi ^a   Pathare, Pradip M ^a   Quinn, Janna ^a   Vessella, Robert L ^a   Foulon, Catherine ^b   Zalutsky, Michael ^b   Wedge, Timothy J ^c   Hawthorne, M Frederick ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDES; ANILINE; ASTATINE; MIXTURES; THIOUREAS;

ANILINE DERIVATIVES; BENZAMIDES; CARBORANES; CO-INJECTION; HIPPURIC ACID; IN-VIVO; MINOR COMPONENTS; N-PROPYL; PROPIONAMIDES; VIVO EVALUATION;

HALOGENATION;

1 (4 CARBORANYLPHENYL) 3 PROPYLTHIOUREA; 1 (4 CARBORANYLPHENYL) 3 PROPYLUREA; 3 (CARBORANYL) N PROPYLPROPIONAMIDE; 3 (CARBORANYL) N [3 (3 PROPYLTHIOUREIDO)PHENYL]PROPIONAMIDE; 3 (CARBORANYL) N [3 [(3 BENZYLPENTETIC ACID)UREIDO]PHENYL]PROPIONAMIDE; 3 (CARBORANYL)PROPIONIC ACID; 3 (IODOCARBORANYL)PROPIONIC ACID I 131; 4 (CARBORANYL)ANILINE; 4 TRI N BUTYLSTANNYLHIPPURIC ACID; 4 [[3,4 BIS(CARBORANYLMETHYL)PHENYL]UREIDO]BENZYLPENTETIC ACID; ASTATINE; ASTATINE 211; BENZAMIDE DERIVATIVE; BORANE DERIVATIVE; ETHYL 4 TRI N BUTYLSTANNYLHIPPURATE; IODINE 125; IODINE 131; N PROPYL 3 (TRI N BUTYLSTANNYL)BENZAMIDE; N PROPYL 4 (TRI N BUTYLSTANNYL)BENZAMIDE; RADIOACTIVE IODINE; REAGENT; THIOUREA DERIVATIVE; TIN; UNCLASSIFIED DRUG; [IODO BIS(CARBORANYLMETHYL)]BENZENE;

ARTICLE; ASTATINATION; BLOOD; CHEMICAL BOND; CHEMICAL MODIFICATION; DRUG RELEASE; HALOGENATION; IODINATION; ISOTOPE LABELING; LUNG; MEAN RESIDENCE TIME; MOLECULAR STABILITY; MOLECULE; MOUSE; NONHUMAN; RADIOISOTOPE DISTRIBUTION; SPLEEN; SYNTHESIS; TISSUE DISTRIBUTION; VENUS FLYTRAP COMPLEX;

DIONAEA; STAPHYLOCOCCUS PHAGE 3A;

EID: 10744222244     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc034175k     Document Type: Article

References (61)

1. 211At labeling of humanized anti-Tac. Nucl. Med. Biol. 28, 845-856.
2. 211At]-Astatobenzyl)guanidine: Synthesis via Astato Demetalation and Preliminary in Vitro and In Vivo Evaluation. Bioconjugate Chem. 3, 499-503.
3. 211At]Astatobenzylguanidine in an Athymic Mouse Human Neuroblastoma Xenograft Model. Nucl. Med. Biol. 23, 851-856.
4. Grimes, R. N. (1970) Structures and Bonding. In Carboranes, pp 5-22, Academic Press, New York.
5. Feinendegen, L. E., and McClure, J. J. (1997) Alpha-Emitters for Medical Therapy - Workshop of the United States Department of Energy. Radiat. Res. 148, 195-201.
6. Wilbur, D. S. (1991) Potential use of alpha emitting radio-nuclides in the treatment of cancer. Antibody, Immunoconjugates, Radiopharm. 4, 85-97.
7. Zalutsky, M. R., and Bigner, D. D. (1996) Radioimmunotherapy With α-Particle Emitting Radioimmunoconjugates. Acta Oncol. 35, 373-379.
8. Breitz, H. B., Weiden, P. L., and Beaumier, P. L. (2000) Radioimmunotherapy of Solid Tumors. In Radioimmunotherapy of Cancer (P. G. Abrams, and A. R. Fritzberg, Eds.) pp 265-307, Marcel Dekker, Inc., New York.
9. Kairemo, K. J. A. (1996) Radioimmunotherapy of Solid Cancers. Acta Oncol. 35, 343-355.
10. DeNardo, S. J., Kroger, L. A., and DeNardo, G. L. (1999) A new era for radiolabeled antibodies in cancer? Curr. Opin. Immunol. 11, 563-569.
11. Goldenberg, D. M. (2002) Targeted therapy of cancer with radiolabeled antibodies. J. Nucl. Med. 43, 693-713.
12. von Mehren, M., Adams, G. P., and Weiner, L. M. (2003) Monoclonal antibody therapy for cancer. Annu. Rev. Med. 54, 343-369.
13. Reubi, J. C. (1997) Regulatory peptide receptors as molecular targets for cancer diagnosis and therapy. Q. J. Nucl. Med. 41, 63-70.
14. Heppeler, A., Froidevaux, S., Eberle, A. N., and Maecke, H. R. (2000) Receptor targeting for tumor localisation and therapy with radiopeptides. Curr. Med. Chem. 7, 971-994.
15. Vaughan, A. T. M., and Fremlin, J. H. (1977) The Preparation of Astatotyrosine. Int. J. Appl. Radiat. Isot. 28, 595-598.
16. Visser, G. W. M., Diemer, E. L., and Kaspersen, F. M. (1979) The Preparation and Stability of Astatotyrosine and Astato-iodotyrosine. Int. J. Appl. Radati. Isot. 30, 749-752.
17. Vaughan, A. T. M., and Fremlin, J. H. (1978) The Preparation of Astatine Labeled Proteins Using an Electrophilic Reaction. Int. J. Nucl. Med. Biol. 5, 229-230.
18. Visser, G. W. M., Diemer, E. L., and Kaspersen, F. M. (1981) The Nature of the Astatine-Protein Bond. Int. J. Appl. Radiat. Isot. 32, 905-912.
19. Friedman, A. M., Zalutsky, M. R., Wung, W., Buckingham, F., Harper, P. V., Scherr, G. H., Wainer, B., Hunter, R. L., Appelman, E. H., Rothberg, R. M., Fitch, F. W., Stuart, F. P., and Simonian, S. J. (1977) Preparation of a Biologically Stable and Immunologically Competent Astatinated Protein. Int. J. Nucl. Med. Biol. 4, 219-224.
20. 211At using an Acylation Reaction. Int. J. Appl. Radiat. Isot. 30, 576-577.
21. 211At-IgG Conjugate which is Stable in vivo. Int. J. Appl. Radiat. Isot. 35, 1005-1008.
22. Zalutsky, M. R., and Narula, A. S. (1988) Astatination of Proteins using an N-Succinimidyl Tri-n-Butylstannyl Benzoate Intermediate. Appl. Radiat. Isot. 39, 227-232.
23. 125I]iodobenzoyl conjugate. Bioconjugate Chem. 2, 171-179.
24. 2 Fragment Labeled With N-Succinimidyl 2,4-Dimethoxy-3-halobenzoates: In Vivo Comparison of Iodinated and Astatinated Fragments. Nucl. Med. Biol. 21, 105-110.
25. Coenen, H. H., Moerlein, S. M., and Stöklin, G. (1983) No-Carrier-Added Radiohalogenation Methods with Heavy Halogens. Radiochim. Acta 34, 47-68.
26. Wilbur, D. S. (1992) Radiohalogenation of proteins: An overview of radionuclides, labeling methods and reagents for conjugate labeling. Bioconjugate Chem. 3, 432-470.
27. Kabalka, G. W., and Varma, R. S. (1989) The Synthesis of Radiolabeled Compounds Via Organometallic Intermediates. Tetrahedron 45, 6601-6621.
28. 11]. Inorg. Chem. 24, 1911-1916.
29. Varadarajan, A., Sharkey, R. M., Goldenberg, D. M., and Hawthorne, M. F. (1991) Conjugation of Phenyl Isothiocyanate Derivatives of Carborane to Antitumor antibody and in Vivo Localization of Conjugates in Nude Mice. Bioconjugate Chem. 2, 102-110.
30. Wilbur, D. S., Hamlin, D. K., and Srivastava, R. R. (1994) Radioiodinations of nido-Carboranes. Potential Hydrophilic Pendant Groups for Radiohalogenation of Biological Molecules. J. Labelled Compd. Radiopharm. 35, 199-201.
31. Kerr, J. A. (1993) Strengths of Chemical Bonds. In CRC Handbook of Chemistry and Physics (D. R. Lide, Ed.) pp 9-123-9-145, CRC Press, Boca Raton.
32. Paxton, R. J., Beatty, B. G., Hawthorne, M. F., Varadarajan, A., Williams, L. E., Curtis, F. L., Knobler, C. B., and Shively, J. E. (1991) A Transition metal complex (Venus flytrap cluster) for radioimmunodetection and radioimmunotherapy. Proc. Natl. Acad. Sci. U.S.A. 88, 3387-3391.
33. Varadarajan, A., Johnson, S. E., Gomez, F. Z., Chakrabarti, S., Knobler, C. B., and Hawthorne, M. F. (1992) Synthesis and Structural Characterization of Pyrazole-Bridged Metalla-Bis(dicarbollide) Derivatives of Cobalt, Nickel, Copper, and Iron: Models for Venus Flytrap Cluster Reagents. J. Am. Chem. Soc. 114, 9003-9011.
34. Hawthorne, M. F., and Maderna, A. (1999) Applications of radiolabeled boron clusters to the diagnosis and treatment of cancer. Chem. Rev. 99, 3421-3434.
35. Gamper, H. B., Reed, M. W., Cox, T., Virosco, J. S., Adams, A. D., Gall, A. A., Scholler, J. K., and Meyer, R. B. (1993) Facile Preparation of Nuclease Resistant 3′ Modified Oligodeoxynucleotides. Nucleic Acids Res. 21, 145-150.
36. 2 fragments with the α-particle-emitting nuclide astatine-211: Preservation of Immunoreactivity and in vivo localizing capacity. Proc. Natl. Acad. Sci. U.S.A. 86, 7149-7153.
37. 2. Nucl. Med. Biol. 20, 917-927.
38. Wilbur, D. S., Hamlin, D. K., Pathare, P. M., and Weerawarna, S. A. (1997) Biotin reagents for antibody pretargeting. Synthesis, radioiodination and in vitro evaluation of water soluble, biotinidase resistant biotin derivatives. Bioconjugate Chem. 8, 572-584.
39. Gomez, F. A., Johnson, S. E., and Hawthorne, M. F. (1991) A Versatile Protecting Group for 1,2-Dicarba-closo-dodecaborane(12) and the Structure of a Silylcarborane Derivative. J. Am. Chem. Soc. 113, 5915-5917.
40. Heying, T. L., Ager, J. W., Clark, S. L., Mangold, D. J., Goldstein, H. L., Hillman, M., Polak, R. J., and Szymanski, J. W. (1963) A New Series of Organoboranes. I. Carboranes from the Reaction of Decaborane with Acetylenic Compounds. Inorg. Chem. 2, 1089-1092.
41. Olsen, F. P., and Hawthorne, M. F. (1965) Halodicarbaundecaborate(II) Ions. Inorg. Chem. 4, 1839-1840.
42. Zalutsky, M. R., and Vaidyanathan, G. (2000) Astatine-211-labeled radiotherapeuties: an emerging approach to targeted alpha-particle radiotherapy. Curr. Pharm. Des. 6, 1433-1455.
43. Arano, Y., Wakisaka, K., Ohmomo, Y., Uezono, T., Mukai, T., Motonari, H., Shiono, H., Sakahara, H., Konishi, J., Tanaka, C., and Yokoyama, A. (1994) Maleimidoethyl 3-(Trin-butylstannyl)hippurate: A Useful Radioiodination Reagent for Protein Radiopharmaceuticals to Enhance Target Selective Radioactivity Localization. J. Med. Chem. 37, 2609-2618.
44. Arano, Y., Wakisaka, K., Mukai, T., Uezono, T., Motonari, H., Akizawa, H., Kairiyama, C., Ohmomo, Y., Tanaka, C., Ishiyama, M., Sakahara, H., Konishi, J., and Yokoyama, A. (1996) Stability of a Metabolizable Ester Bond in Radioimmunoconjugates. Nucl. Med. Biol. 23, 129-136.
45. Wilbur, D. S., Hamlin, D. K., Kegley, B. B., Chyan, M. K., Pathare, P. M., and Wan, F. (2001) Studies Which Indicate That Thiourea Bonds Interfere With Radioiodination Reactions. J. Labelled Compd. Radiopharm. 44, S973-S975.
46. Wilbur, D. S., Chyan, M. K., Hamlin, D. K., Kegley, B. B., Nilsson, R., Sandberg, B. E., and Brechbiel, M. (2002) Trifunctional conjugation reagents. Reagents that contain a biotin and a radiometal chelation moiety for application to extracorporeal affinity adsorption of radiolabeled antibodies. Bioconjugate Chem. 13, 1079-1092.
47. Trejtnar, F., and Laznicek, M. (2002) Analysis of renal handling of radiopharmaceuticals. Q. J. Nucl. Med. 46, 181-194.
48. Hamilton, J. G., Asling, C. W., Garrison, W. M., and Scott, K. G. (1953) The Accumulation, Metabolism and Biological Effects of Astatine in Rats and Monkeys. Univ. Calif. Publ. Pharmacol. 2, 283-343.
49. 211At]Astato-N-piperidinoethyl Benzamide. Nucl. Med. Biol. 22, 467-473.
50. 211) Organic Compounds for Production of Highly Localized Radiobiological Effects. Am. Soc. Biol. Chem. 14, 229.
51. Friedman, A. M. (1978) Radioastatine: Possible Uses of a Heavy Halogen. In Therapy in Nuclear Medicine (R. P. Spencer, Ed.) pp 139-144, Grune & Stratton, New York.
52. Brown, I. (1987) Astatine: Its Organonuclear Chemistry and Biomedical Applications. Adv. Org. Chem. 31, 43-88.
53. Brown, I. (1986) Astatine-211: Its Possible Applications in Cancer Therapy. Appl. Radiat. Isot. 37, 789-798.
54. Wilbur, D. S. (1991) Potential use of alpha-emitting radionuclides in the treatment of cancer. Antibody, Immunoconjugates, Radiopharm. 4, 85-97.
55. Visser, G. W. M., Diemer, E. L., Vos, C. M., and Kaspersen, F. M. (1981) The Biological Behaviour of Some Organic Astatine Compounds in Rats. Int. J. Appl. Radiat. Isot. 32, 913-917.
56. 2 Fragment. Cancer Res. 50, 3514-3520.
57. Berei, K., and Vasáros, L. (1983) Organic chemistry of astatine. The Chemistry of Functional Groups, Supplement D (S. Patai, and Z. Rappoport, Eds.) pp 405-440, John Wiley & Sons Ltd, New York.
58. Orlova, A., Lebeda, O., Tolmachev, V., Sjoberg, S., Carlsson, J., and Lundqvist, H. (2000) Closo-dodecaborate (2-) anion as a potential prosthetic group for attachment of astatine to proteins. Aspects of the labeling chemistry with Chloramine-T. J. Labelled Compd. Radiopharm. 43, 251-260.
59. Orlova, A., Lebeda, O., Tolmachev, V., Sjoberg, S., Carlsson, J., and Lundqvist, H. (1999) Astatination of Closo-Dodecaborate(2-) Anion. J. Labelled Compd. Radiopharm. 42, S735-S737.
60. Varvoglis, A. (1992) Iodonium Salts. In The Organic Chemistry of Polycoordinated Iodine, pp 207-306, VCH Publishers, Inc.,
61. Zhdankin, V. V., and Stang, P. J. (2002) Recent Developments in the Chemistry of Polyvalent Iodine Compounds. Chem. Rev. 102, 2523-2584.